He received his undergraduate degree from the University of Chicago, MD from George Washington University and his post-graduate training in Internal Medicine, Medical Oncology and Infectious Diseases at New York Hospital/Cornell and Memorial Sloan-Kettering Cancer Center. In 2008, Dr. Weinstock moved to the Dana-Farber Cancer Institute and Harvard Medical School, where he directs a translational research program focused on novel therapeutic targets in lymphoid malignancies. He has authored over 80 peer-reviewed manuscripts and book chapters on topics ranging from cancer pathogenesis to infections among immunocompromised hosts to mechanisms of DNA damage response to nuclear terrorism preparedness.